Civic Intelligence

Path Vaccine Solutions

990 • Fiscal year 2016 • EIN 83-0431851

Jan 01, 2016 to Dec 31, 2016 • Filed on Nov 14, 2017

Organization ProfileWWW.PATH.ORG
2201 Westlake Avenue No 200Seattle, WA 98121

(206) 285-3500

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

28th percentile

0.15x

Higher debt load relative to assets than 28% of similar nonprofits.

2016 filings • 501(c)3 • $100M-$250M nonprofits • Source year 2016

Liabilities / Revenue

86th percentile

2.64x

Higher debt load relative to revenue than 86% of similar nonprofits.

2016 filings • 501(c)3 • $100M-$250M nonprofits • Source year 2016

Net Margin

1st percentile

-602%

Higher net margin than 1% of similar nonprofits.

2016 filings • 501(c)3 • $100M-$250M nonprofits • Source year 2016

Top Officer Pay

66th percentile

$685,314

Higher top officer pay than 66% of similar nonprofits.

Top officer pay equals 11.4% of source-year revenue.

2016 filings • 501(c)3 • $100M-$250M nonprofits • Source year 2016

Asset Growth

2nd percentile

-29%

Faster asset growth than 2% of similar nonprofits.

2016 filings • 501(c)3 • $100M-$250M nonprofits • Annualized from 2015 to 2016

Revenue Growth

1st percentile

-87%

Faster revenue growth than 1% of similar nonprofits.

2016 filings • 501(c)3 • $100M-$250M nonprofits • Annualized from 2015 to 2016

Balance Sheet
Liabilities / Assets28th percentile

Assets

Down

$107,465,507

Down $43,364,958 (-29%) from 2015

Net Assets

Down

$91,662,106

Down $55,108,512 (-38%) from 2015

Liabilities

Up

$15,803,401

Up $11,743,554 (+289%) from 2015

Revenue And Expenses
Liabilities / Revenue86th percentileNet Margin1st percentile

Revenue

Down

$5,990,503

Down $40,744,369 (-87%) from 2015

Expenses

Up

$42,072,773

Up $3,675,704 (+9.6%) from 2015

Net Income

Down

-$36,082,270

Down $44,420,073 (-533%) from 2015

Historical Trend

Balance Sheet Trend

Asset Growth2nd percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$200M$150M$100M$50M$0Assets 2010: $151,102,797Liabilities 2010: $4,781,234Net Assets 2010: $146,321,5632010Assets 2011: $133,507,981Liabilities 2011: $6,691,219Net Assets 2011: $126,816,7622011Assets 2012: $142,045,531Liabilities 2012: $2,850,743Net Assets 2012: $139,194,7882012Assets 2013: $166,859,076Liabilities 2013: $6,024,155Net Assets 2013: $160,834,9212013Assets 2014: $149,044,550Liabilities 2014: $10,278,308Net Assets 2014: $138,766,2422014Assets 2015: $150,830,465Liabilities 2015: $4,059,847Net Assets 2015: $146,770,6182015Assets 2016: $107,465,507Liabilities 2016: $15,803,401Net Assets 2016: $91,662,1062016Assets 2017: $66,391,789Liabilities 2017: $14,042,965Net Assets 2017: $52,348,8242017Assets 2018: $38,472,788Liabilities 2018: $37,875,254Net Assets 2018: $597,5342018Assets 2019: $38,989,543Liabilities 2019: $36,842,677Net Assets 2019: $2,146,8662019

Highlighted filing

2016

Assets$107,465,507
Liabilities$15,803,401
Net Assets$91,662,106
Open 2016 Filing

Operations Trend

Revenue Growth1st percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$100M$50M$0-$50MExpenses 2010: $35,920,9952010Revenue 2011: $18,181,537Expenses 2011: $37,226,565Net Income 2011: -$19,045,0282011Revenue 2012: $52,130,143Expenses 2012: $40,164,028Net Income 2012: $11,966,1152012Revenue 2013: $59,399,215Expenses 2013: $37,490,390Net Income 2013: $21,908,8252013Revenue 2014: $24,771,754Expenses 2014: $47,169,027Net Income 2014: -$22,397,2732014Revenue 2015: $46,734,872Expenses 2015: $38,397,069Net Income 2015: $8,337,8032015Revenue 2016: $5,990,503Expenses 2016: $42,072,773Net Income 2016: -$36,082,2702016Revenue 2017: $7,108,916Expenses 2017: $43,734,346Net Income 2017: -$36,625,4302017Revenue 2018: $35,807,318Expenses 2018: $35,391,575Net Income 2018: $415,7432018Revenue 2019: $10,961,263Expenses 2019: $9,746,391Net Income 2019: $1,214,8722019

Highlighted filing

2016

Revenue$5,990,503
Expenses$42,072,773
Net Income-$36,082,270
Open 2016 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2016 to Dec 31, 2016
Signed
Nov 14, 2017
Return Version
2016v3.0
Gross Receipts
$30,037,748
Mission and Program Overview

Mission

The mission of path vaccine solutions (pvs) is to improve the health of children in low-income countries by accelerating the development of vaccines that will be effective and affordable for those who need them most. From initial discovery through clinical trials, pvs works with commercial partners, such as vaccine manufacturers and biotechnology firms, and nonprofit partners, such as universities and research institutions, to shorten the timeline for vaccine development.pvs works with partners to develop new vaccines by providing funding and expertise in preclinical development, manufacturing, and clinical development, with a focus on low-resource countries. In return, partners agree to terms that help ensure the resulting products are affordable and available in developing countries.

SEE PART III, LINE 1.

Balance Sheet Detail
LineBeginningEndChange
Assets
Investments in Publicly Traded Securities$73,413,349$74,661,038▲ $1,247,689
Pledges and Grants Receivable$59,593,963$32,558,748▼ $27,035,215
Savings and Temporary Cash Investments$17,554,485--
Accounts Receivable$168,331$202,886▲ $34,555
Land, Buildings, and Equipment, Net$100,337$42,765▼ $57,572
Prepaid Expenses and Deferred Charges-$70-
Total Assets$150,830,465$107,465,507▼ $43,364,958
Liabilities
Accounts Payable and Accrued Expenses$4,059,847$15,803,401▲ $11,743,554
Total Liabilities$4,059,847$15,803,401▲ $11,743,554
Net Assets / Fund Balance
Temporarily Rstr Net Assets$146,752,511$91,643,999▼ $55,108,512
Unrestricted Net Assets$18,107$18,107→ $0
Total Net Assets Fund Balance$146,770,618$91,662,106▼ $55,108,512
Total Liabilities and Net Assets / Fund Balance$150,830,465$107,465,507▼ $43,364,958

Asset Categories

AssetBook ValueDepreciationBasis
Equipment$42,765$191,510$234,275
Compensation and Service Providers
Top Officer Pay66th percentile

Employees

NameTitleFull / Part TimeOtherTotal
David a AlliSecretary (until 05/2016)PT$96,142$96,142

Board Members and Trustees

NameTitle
Stephen B DavisChair and President
Penny HeatonVice Chair
Amie E BatsonDirector
Chris KarpDirector
David C KaslowDirector
Daniel LasterSecretary
Olivia D PoliusTreasurer

Highest Paid Contractors

ContractorServicesLocationCompensation
Northern TrustAsset Management50 S LASALLE ST, Chicago, IL 60675$201,668
Revenue and Support

Revenue Composition

Contributions and Grants
$4,727,165
Program Service Revenue
$0
Investment Income
$1,239,778
Other Revenue
$23,560
All Other Contributions
$4,445,136
Change in Net Assets
$-36,082,270
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Grants and Similar Amounts Paid$29,855,678
Other Expenses$12,217,095
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Grants to Domestic Orgs$22,086,517--$22,086,517
Foreign Grants$7,769,161--$7,769,161
Travel$1,644,562--$1,644,562
Fees for Services Other$470,985--$470,985
Conferences and Meetings$325,150--$325,150
Office Expenses$223,044--$223,044
Fees for Service Investment Mgmnt Fees$201,668--$201,668
Insurance$124,965--$124,965
Depreciation Depletion$64,306--$64,306
Other Expenses$22,611--$22,611
All Other Expenses$13,017--$13,017
Royalties$9,738--$9,738
Fees for Services Legal$8,629--$8,629
Information Technology$8,137--$8,137
Advertising$5,731--$5,731
Total Functional Expenses$42,072,773$0$0$42,072,773
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
PathSeattle, WA501(c)(3)Product Development$15,502,397
Infectious Disease Research InstituteSeattle, WA501(c)(3)Product Development$1,454,597
University of Maryland BaltimoreBaltimore, MD501(c)(3)Product Development$770,526
Walter Reed Army Institute of ResearchSilver Spring, MDGovProduct Development$632,903
Icahn School of Medicine at Mount SinaiNew York, NY501(c)(3)Product Development$600,000
Johns Hopkins UniversityBaltimore, MD501(c)(3)Product Development$561,271
Henry M Jackson FoundationBethesda, MD501(c)(3)Product Development$466,840
United States Naval Medical Research CenterSilver Spring, MDGovProduct Development$379,450
University of Maryland School of Medicine Center for Vaccine DevelopmentBaltimore, MD501(c)(3)Product Development$260,591
Jhu Bloomberg School of Public HealthBaltimore, MD501(c)(3)Product Development$254,007
University of Alabama at BirminghamBirmingham, AL501(c)(3)Product Development$200,000
BOSTON CHILDREN'S HOSPITALBoston, MA501(c)(3)Product Development$174,830
Affinivax IncLexington, MAN/aProduct Development$172,067
Washington University in St LouisSt Louis, MO501(c)(3)Product Development$161,862
Sabin Vaccine InstituteWashington, DC501(c)(3)Product Development$100,000
Family Health International 360Durham, NC501(c)(3)Product Development$99,476
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTERCincinnati, OH501(c)(3)Product Development$86,603
Lankenau Institute for Medical ResearchWynnewood, PA501(c)(3)Product Development$58,334
Fina Biosolutions LLCRockville, MDN/aProduct Development$52,917
University of FloridaGainesville, FL501(c)(3)Product Development$41,325
Harvard University School of Public HealthBoston, MA501(c)(3)Product Development$38,326
Tulane Educational FundNew Orleans, LA501(c)(3)Product Development$19,800
Board of Trustees of the University of AlabamaBirmingham, AL501(c)(3)Product Development$-6,255

International Summary

Offices
0
Employees
9
Spending
$11,716,751

International Compliance

Foreign grant records maintained
Yes
Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
Yes

International Activities

RegionActivityServicesOfficesEmployeesSpending
South AsiaGrantmaking-00$4,771,246
EuropeGrantmakingEssential Medicine00$1,426,409
South AsiaProgram Services-08$1,341,689
EuropeProgram ServicesEssential Medicine00$1,267,343
Sub-saharan AfricaGrantmaking-00$1,234,197
Sub-saharan AfricaProgram Services-01$1,139,654
East Asia and the PacificGrantmakingEssential Medicine00$237,309
East Asia and the PacificProgram ServicesEssential Medicine00$189,968
South AmericaGrantmaking-00$100,000
South AmericaProgram ServicesEssential Medicine00$8,147
North AmericaProgram ServicesEssential Medicine00$789
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
Yes
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

“The form 990 was prepared by an outside accounting firm (gelman, rosenberg & freedman cpas) using information provided by path accounting services staff. Path senior management reviewed the draft form. A copy of the draft was sent to path's board of directors for comment. After the comment period, the chief financial officer signed and filed the return.”

Form 990, Part VI, Section B, Line 12C

“Pvs has a written conflict of interest policy under which all pvs board members and officers must complete a conflict of interest disclosure form each year. Pvs does not have employees. Pvs is a supporting organization to path within the meaning of internal review code section 509(a)(3), and pvs contracts with path for management services. Path has a written conflict of interest policy under which all path board members, officers, and staff at higher than a designated level must complete a conflict of interest disclosure form each year. All pvs and path disclosure forms are reviewed and kept on file. A conflict management plan is developed for any employee with a significant actual or perceived conflict of interest.”

Form 990, Part VI, Section C, Line 19

“Pvs's governing documents, conflict of interest policy, and financial statements are available to the public upon request; most documents are also available online.”

Filing and Contact Details

Filer

Filer Name
Path Vaccine Solutions
EIN
83-0431851
Phone
2062853500
Address
2201 WESTLAKE AVENUE NO 200, SEATTLE, WA 98121

Signing Officer

Name
Olivia D Polius
Title
Chief Financial Officer
Phone
2062853500
Signed
2017-11-14
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Olivia D Polius
Formed
2006
Legal Domicile
Wa
Voting Board Members
7
Independent Board Members
2
Employees
0
Volunteers
0

Preparer

Firm
Gelman Rosenberg & Freedman
Address
4550 MONTGOMERY AVE SUITE 650N, BETHESDA, MD 20814-2930
Phone
3019519090
Supplemental Narrative

Additional Explanations

FORM 990, PART XI, LINE 9:

“From time to time, unspent award funds (or unused obligations) may be returned to a funder for a variety of reasons including, but not limited to, early termination of a project by a funder, or a reduction in funds required to accomplish a project's scope of work. -19,152,441.”

Raw XML AppendixShowing 400 of 958 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt04059847
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt015803401
IRS990/AccountsReceivableGrp/BOYAmt0168331
IRS990/AccountsReceivableGrp/EOYAmt0202886
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0SEE PART III, LINE 1.
IRS990/AdvertisingGrp/ProgramServicesAmt05731
IRS990/AdvertisingGrp/TotalAmt05731
IRS990/AllOtherContributionsAmt04445136
IRS990/AllOtherExpensesGrp/ProgramServicesAmt013017
IRS990/AllOtherExpensesGrp/TotalAmt013017
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0OLIVIA POLIUS CHIEF FINANCIAL OFFICER
IRS990/BooksInCareOfDetail/PhoneNum02062853500
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt02201 WESTLAKE AVE SUITE 200
IRS990/BooksInCareOfDetail/USAddress/CityNm0SEATTLE
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0WA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd098121
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOfficerEntInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt01
IRS990/CollectionsOfArtInd00
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd00
IRS990/CompensationProcessOtherInd00
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt0325150
IRS990/ConferencesMeetingsGrp/TotalAmt0325150
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd01
IRS990/ContractorCompensationGrp/CompensationAmt0201668
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt050 S LASALLE ST
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm0CHICAGO
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd0IL
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd060675
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt0NORTHERN TRUST
IRS990/ContractorCompensationGrp/ServicesDesc0ASSET MANAGEMENT
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt04727165
IRS990/CYGrantsAndSimilarPaidAmt029855678
IRS990/CYInvestmentIncomeAmt01239778
IRS990/CYOtherExpensesAmt012217095
IRS990/CYOtherRevenueAmt023560
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0-36082270
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt042072773
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt05990503
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/ProgramServicesAmt064306
IRS990/DepreciationDepletionGrp/TotalAmt064306
IRS990/Desc0PVS WORKS TO PREVENT DEATH AND DISEASE CAUSED BY DIARRHEA, PNEUMONIA, INFLUENZA, RESPIRATORY SYNCYTIAL VIRUS, AND POLIO AMONG CHILDREN AROUND THE WORLD. WE ACCELERATE THE DEVELOPMENT OF SAFE, EFFICACIOUS, AND AFFORDABLE VACCINES IN PARTNERSHIP WITH PUBLIC AND PRIVATE GROUPS. IN 2016, PVS CONTINUED OUR FIGHT AGAINST DIARRHEAL DISEASES, THE SECOND LEADING CAUSE OF DEATH AMONG CHILDREN IN LOW-INCOME COUNTRIES. TO COMBAT ROTAVIRUS, A MAJOR CAUSE OF SEVERE DIARRHEA, WE CONTINUED TO PARTNER WITH SIIPL TO STUDY A VACCINE THAT MAY REMAIN STABLE AND POTENT EVEN DURING EXTENDED PERIODS WITHOUT REFRIGERATION, ENABLING WIDER USE IN REMOTE COMMUNITIES. WE CONDUCTED A PHASE 3 EFFICACY STUDY OF THE VACCINE, AS WELL AS A STUDY TO EXAMINE CLINICAL LOT CONSISTENCY AND POTENTIAL INTERFERENCE WITH ROUTINE VACCINES. SIIPL SUBMITTED PRIMARY DATA FROM THE EFFICACY STUDY TO THE INDIAN REGULATORY AUTHORITIES, AND THE VACCINE ACHIEVED LICENSURE IN DECEMBER 2016. IN ADDITION, ROTAVAC, ANOTHER INDIAN-MADE VACCINE DEVELOPED WITH PATH SUPPORT, BEGAN A PHASED ROLLOUT IN INDIA'S NATIONAL IMMUNIZATION PROGRAM IN MARCH 2016. [ROTAVAC IS A REGISTERED TRADEMARK OF BHARAT BIOTECH.]WE ALSO CONTINUED TO CONDUCT EARLY-STAGE CLINICAL TRIALS OF VACCINE CANDIDATES THAT MAY PROVIDE PROTECTION AGAINST ENTEROTOXIGENIC ESCHERICHIA COLI (ETEC) AND SHIGELLA, LEADING CAUSES OF BACTERIAL DIARRHEAL ILLNESS. IN ADDITION, WE HOSTED THE FIRST INTERNATIONAL VACCINES AGAINST SHIGELLA AND ETEC (VASE) CONFERENCE JUNE 28 TO 30, 2016, IN WASHINGTON, DC. THE MEETING BROUGHT TOGETHER MORE THAN 250 SCIENTISTS, PUBLIC HEALTH PROFESSIONALS, IMMUNIZATION LEADERS, VACCINE INDUSTRY REPRESENTATIVES, DONORS, AND OTHER EXPERTS FROM APPROXIMATELY 30 COUNTRIES. THE AGENDA FEATURED 23 ABSTRACT-BASED ORAL PRESENTATIONS AND 32 ABSTRACT-BASED POSTER PRESENTATIONS, AND THE CONFERENCE HELPED MAINTAIN THE MOMENTUM FOR SHIGELLA AND ETEC VACCINE RESEARCH AND DEVELOPMENT ACROSS THE ENTERIC VACCINE FIELD.WE ALSO ADVANCED DEVELOPMENT OF LOW-COST VACCINE CANDIDATES TO PROTECT CHILDREN AGAINST PNEUMOCOCCAL BACTERIA, THE TOP CAUSE OF SEVERE CHILDHOOD PNEUMONIA. IN THE GAMBIA, FOR INSTANCE, WE EVALUATED A PNEUMOCOCCAL CONJUGATE VACCINE (PCV-10) CANDIDATE DESIGNED TO BE AFFORDABLE AND TO PROVIDE PROTECTION AGAINST THE TEN BACTERIAL SEROTYPES THAT CAUSE THE MOST CASES OF INVASIVE PNEUMOCOCCAL DISEASE IN AFRICA AND ASIA. IN KENYA, WE STUDIED A VACCINE CANDIDATE WITH THE POTENTIAL TO PROVIDE LOW-COST, BROAD PROTECTION ACROSS MANY SEROTYPES.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt042072773
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt08629
IRS990/FeesForServicesLegalGrp/TotalAmt08629
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt0470985
IRS990/FeesForServicesOtherGrp/TotalAmt0470985
IRS990/FeesForSrvcInvstMgmntFeesGrp/ProgramServicesAmt0201668
IRS990/FeesForSrvcInvstMgmntFeesGrp/TotalAmt0201668
IRS990/ForeignActivitiesInd01
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignGrantsGrp/ProgramServicesAmt07769161
IRS990/ForeignGrantsGrp/TotalAmt07769161
IRS990/ForeignOfficeInd01
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt039.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt10.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt239.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt339.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt439.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt539.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt60.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt720.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt01.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt51.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt61.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt720.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd3X
IRS990/Form990PartVIISectionAGrp/OfficerInd4X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt062041
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt248805
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt342894
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt426850
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt563492
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt710994
IRS990/Form990PartVIISectionAGrp/PersonNm0STEPHEN B DAVIS
IRS990/Form990PartVIISectionAGrp/PersonNm1PENNY HEATON
IRS990/Form990PartVIISectionAGrp/PersonNm2OLIVIA D POLIUS
IRS990/Form990PartVIISectionAGrp/PersonNm3DANIEL LASTER
IRS990/Form990PartVIISectionAGrp/PersonNm4AMIE E BATSON
IRS990/Form990PartVIISectionAGrp/PersonNm5DAVID C KASLOW
IRS990/Form990PartVIISectionAGrp/PersonNm6CHRIS KARP
IRS990/Form990PartVIISectionAGrp/PersonNm7DAVID A ALLI
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt0623273
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt2303385
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt3304582
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt4293566
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt5354854
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt785148
IRS990/Form990PartVIISectionAGrp/TitleTxt0CHAIR AND PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1VICE CHAIR
IRS990/Form990PartVIISectionAGrp/TitleTxt2TREASURER
IRS990/Form990PartVIISectionAGrp/TitleTxt3SECRETARY
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt7SECRETARY (UNTIL 05/2016)
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02006
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/ConsolidatedBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GainOrLossGrp/SecuritiesAmt0216436
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt07
IRS990/GrantAmt029855678
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt022086517
IRS990/GrantsToDomesticOrgsGrp/TotalAmt022086517
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt024263681
IRS990/GrossReceiptsAmt030037748
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt02
IRS990/IndivRcvdGreaterThan100KCnt00
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIInd0X
IRS990/InformationTechnologyGrp/ProgramServicesAmt08137
IRS990/InformationTechnologyGrp/TotalAmt08137
IRS990/InsuranceGrp/ProgramServicesAmt0124965
IRS990/InsuranceGrp/TotalAmt0124965
IRS990/InvestmentIncomeGrp/ExclusionAmt01023342
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt01023342
IRS990/InvestmentInJointVentureInd00
IRS990/InvestmentsPubTradedSecGrp/BOYAmt073413349
IRS990/InvestmentsPubTradedSecGrp/EOYAmt074661038
IRS990/IRPDocumentCnt00
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt0191510
IRS990/LandBldgEquipBasisNetGrp/BOYAmt0100337
IRS990/LandBldgEquipBasisNetGrp/EOYAmt042765
IRS990/LandBldgEquipCostOrOtherBssAmt0234275
IRS990/LegalDomicileStateCd0WA
IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt024047245
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0THE MISSION OF PATH VACCINE SOLUTIONS (PVS) IS TO IMPROVE THE HEALTH OF CHILDREN IN LOW-INCOME COUNTRIES BY ACCELERATING THE DEVELOPMENT OF VACCINES THAT WILL BE EFFECTIVE AND AFFORDABLE FOR THOSE WHO NEED THEM MOST. FROM INITIAL DISCOVERY THROUGH CLINICAL TRIALS, PVS WORKS WITH COMMERCIAL PARTNERS, SUCH AS VACCINE MANUFACTURERS AND BIOTECHNOLOGY FIRMS, AND NONPROFIT PARTNERS, SUCH AS UNIVERSITIES AND RESEARCH INSTITUTIONS, TO SHORTEN THE TIMELINE FOR VACCINE DEVELOPMENT.PVS WORKS WITH PARTNERS TO DEVELOP NEW VACCINES BY PROVIDING FUNDING AND EXPERTISE IN PRECLINICAL DEVELOPMENT, MANUFACTURING, AND CLINICAL DEVELOPMENT, WITH A FOCUS ON LOW-RESOURCE COUNTRIES. IN RETURN, PARTNERS AGREE TO TERMS THAT HELP ENSURE THE RESULTING PRODUCTS ARE AFFORDABLE AND AVAILABLE IN DEVELOPING COUNTRIES.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd01
IRS990/NetAssetsOrFundBalancesBOYAmt0146770618
IRS990/NetAssetsOrFundBalancesEOYAmt091662106
IRS990/NetGainOrLossInvestmentsGrp/ExclusionAmt0216436
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt0216436
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NetUnrlzdGainsLossesInvstAmt0126199
IRS990/NondeductibleContributionsInd00
IRS990/OfficeExpensesGrp/ProgramServicesAmt0223044
IRS990/OfficeExpensesGrp/TotalAmt0223044
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsSFAS117Ind0X
IRS990/OtherChangesInNetAssetsAmt0-19152441
IRS990/OtherExpensesGrp/Desc0SUBCONTRACTORS
IRS990/OtherExpensesGrp/Desc1STORAGE
IRS990/OtherExpensesGrp/Desc2LAB SUPPLIES
IRS990/OtherExpensesGrp/Desc3EQUIPMENT R&M
IRS990/OtherExpensesGrp/ProgramServicesAmt09012149
IRS990/OtherExpensesGrp/ProgramServicesAmt143448
IRS990/OtherExpensesGrp/ProgramServicesAmt238955
IRS990/OtherExpensesGrp/ProgramServicesAmt322611
IRS990/OtherExpensesGrp/TotalAmt09012149
IRS990/OtherExpensesGrp/TotalAmt143448
IRS990/OtherExpensesGrp/TotalAmt238955
IRS990/OtherExpensesGrp/TotalAmt322611
IRS990/OtherRevenueMiscGrp/BusinessCd0900099
IRS990/OtherRevenueMiscGrp/BusinessCd1900099
IRS990/OtherRevenueMiscGrp/Desc0OTHER REIMBURSEMENTS
IRS990/OtherRevenueMiscGrp/Desc1MISCELLANEOUS
IRS990/OtherRevenueMiscGrp/ExclusionAmt012560
IRS990/OtherRevenueMiscGrp/ExclusionAmt111000
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt012560
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt111000
IRS990/OtherRevenueTotalAmt023560
IRS990/OtherWebsiteInd0X
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt059593963
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt032558748
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt070
IRS990/PrincipalOfficerNm0OLIVIA D POLIUS
IRS990/ProfessionalFundraisingInd00
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt045999268
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt028397080
IRS990/PYInvestmentIncomeAmt0733017
IRS990/PYOtherExpensesAmt09999989
IRS990/PYOtherRevenueAmt02587
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt08337803
IRS990/PYSalariesCompEmpBnftPaidAmt00
IRS990/PYTotalExpensesAmt038397069
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt046734872
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt0-36082270
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd01
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/RelatedOrganizationsAmt0282029
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990/RoyaltiesGrp/ProgramServicesAmt09738
IRS990/RoyaltiesGrp/TotalAmt09738
IRS990/SavingsAndTempCashInvstGrp/BOYAmt017554485
IRS990ScheduleA/Form990SchASupportingOrgGrp/Contribution35ControlledInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ContributionControllerInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ContributionFamilyInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ControlledDisqualifiedPrsnInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/DisqualifiedPrsnControllIntInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/DisqualifiedPrsnOwnrIntInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ExcessBusinessHoldingsRulesInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ListedByNameGoverningDocInd01
IRS990ScheduleA/Form990SchASupportingOrgGrp/LoanDisqualifiedPersonInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/OrganizationChangeSuprtOrgInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/PaymentSubstantialContribtrInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportedOrgNotOrganizedUSInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportedOrgSectionC456Ind00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportNonSupportedOrgInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SuprtOrgNoIRSDeterminationInd00
IRS990ScheduleA/Form990SchAType1SuprtOrgGrp/OperateBenefitNonSuprtOrgInd00
IRS990ScheduleA/Form990SchAType1SuprtOrgGrp/PowerAppointMajorityDirTrstInd01
IRS990ScheduleA/OtherSupportSumAmt00
IRS990ScheduleA/SupportedOrganizationsCnt01
IRS990ScheduleA/SupportedOrganizationsTotalCnt01
IRS990ScheduleA/SupportedOrgInformationGrp/EIN0911157127
IRS990ScheduleA/SupportedOrgInformationGrp/GoverningDocumentListedInd01
IRS990ScheduleA/SupportedOrgInformationGrp/OrganizationTypeCd07
IRS990ScheduleA/SupportedOrgInformationGrp/OtherSupportAmt00
IRS990ScheduleA/SupportedOrgInformationGrp/SupportAmt042072773
IRS990ScheduleA/SupportedOrgInformationGrp/SupportedOrganizationName/BusinessNameLine1Txt0PATH
IRS990ScheduleA/SupportingOrganization509a3Ind0X
IRS990ScheduleA/SupportingOrgType1Ind0X
IRS990ScheduleA/SupportSumAmt042072773
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleD/EquipmentGrp/BookValueAmt042765
IRS990ScheduleD/EquipmentGrp/DepreciationAmt0191510
IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt0234275
IRS990ScheduleD/TotalBookValueLandBuildingsAmt042765
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt10
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt20
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt30
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt40
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt50
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt60
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt78
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt80
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt91
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt100
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt110
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt120
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt10
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt20
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt30
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt40
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt50
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt60
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt70
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt80
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt90
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt100
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt110
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt120
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt0189968
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt1237309
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt21267343
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt31426409
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt4789
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt58147
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt6100000
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt71341689
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt84771246
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt91139654
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt101234197
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt0EAST ASIA AND THE PACIFIC
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt1EAST ASIA AND THE PACIFIC
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt2EUROPE
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt3EUROPE
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt4NORTH AMERICA
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt5SOUTH AMERICA
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt6SOUTH AMERICA
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt7SOUTH ASIA
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt8SOUTH ASIA
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt9SUB-SAHARAN AFRICA
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt10SUB-SAHARAN AFRICA
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt0ESSENTIAL MEDICINE
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt1ESSENTIAL MEDICINE
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt2ESSENTIAL MEDICINE
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt3ESSENTIAL MEDICINE
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt4ESSENTIAL MEDICINE
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt5ESSENTIAL MEDICINE
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt0PROGRAM SERVICES
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt1GRANTMAKING
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt2PROGRAM SERVICES
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt3GRANTMAKING
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt4PROGRAM SERVICES
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt5PROGRAM SERVICES
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt6GRANTMAKING
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt7PROGRAM SERVICES
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt8GRANTMAKING
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt9PROGRAM SERVICES
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt10GRANTMAKING
IRS990ScheduleF/BoycottCountriesInd00
IRS990ScheduleF/ContinuationSpentAmt07145097
IRS990ScheduleF/ContinutationTotalEmployeeCnt01
IRS990ScheduleF/ContinutationTotalOfficeCnt00
IRS990ScheduleF/ForeignCorpOwnershipInd00
IRS990ScheduleF/ForeignPartnershipInd00
IRS990ScheduleF/GrantRecordsMaintainedInd01
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt012327
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt11895080
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt250000
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt3228767
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt4100000
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt5133504
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt6466542

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2016 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$107,465,507
Liabilities
$15,803,401
Net assets
$91,662,106
Revenue
$5,990,503
Expenses
$42,072,773
Net income
-$36,082,270
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2019XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$39.0$36.8$2.15$11.0$9.75$1.21
2018XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$38.5$37.9$0.60$35.8$35.4$0.42
2017Facts available. Structured filing facts are available, but richer extracted sections are limited.$66.4$14.0$52.3$7.11$43.7$36.6
2016Detailed filing. Detailed filing data is available for this year.$107$15.8$91.7$5.99$42.1$36.1
2015Detailed filing. Detailed filing data is available for this year.$151$4.06$147$46.7$38.4$8.34
2014Detailed filing. Detailed filing data is available for this year.$149$10.3$139$24.8$47.2$22.4
2013Detailed filing. Detailed filing data is available for this year.$167$6.02$161$59.4$37.5$21.9
2012Summary only. Only limited summary data is available for this year.$142$2.85$139$52.1$40.2$12.0
2011Summary only. Only limited summary data is available for this year.$134$6.69$127$18.2$37.2$19.0
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$151$4.78$146$35.9
Peer Organizations

Similar nonprofits based on the same Siviq industry and scale cohort. 2016 filings • 501(c)3 • $100M-$250M nonprofits